Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update.
J Clin Oncol. 2018 Aug 10;36(23):2433-2443. doi: 10.1200/JCO.2018.78.8604. Epub 2018 May 22.
J Clin Oncol. 2018.
PMID: 29787356
Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline.
Denduluri N, Somerfield MR, Eisen A, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Telli ML, Trudeau ME, Wolff AC.
Denduluri N, et al. Among authors: holloway jn.
J Clin Oncol. 2016 Jul 10;34(20):2416-27. doi: 10.1200/JCO.2016.67.0182. Epub 2016 Apr 18.
J Clin Oncol. 2016.
PMID: 27091714
Item in Clipboard
Reply to L. Del Mastro and A. Prat.
Denduluri N, Somerfield MR, Eisen A, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Telli ML, Trudeau ME, Wolff AC.
Denduluri N, et al. Among authors: holloway jn.
J Clin Oncol. 2017 Apr 1;35(10):1139. doi: 10.1200/JCO.2016.70.9758. Epub 2017 Jan 17.
J Clin Oncol. 2017.
PMID: 28095161
No abstract available.
Item in Clipboard
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Prior Therapies Work Group.
Osarogiagbon RU, Vega DM, Fashoyin-Aje L, Wedam S, Ison G, Atienza S, De Porre P, Biswas T, Holloway JN, Hong DS, Wempe MM, Schilsky RL, Kim ES, Wade JL 3rd.
Osarogiagbon RU, et al. Among authors: holloway jn.
Clin Cancer Res. 2021 May 1;27(9):2408-2415. doi: 10.1158/1078-0432.CCR-20-3854. Epub 2021 Feb 9.
Clin Cancer Res. 2021.
PMID: 33563637
Free PMC article.
Item in Clipboard
Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How.
Salamone JM, Lucas W, Brundage SB, Holloway JN, Stahl SM, Carbine NE, London M, Greenwood N, Goyes R, Chisholm DC, Price E, Carlin R, Winarsky S, Baker KB, Maues J, Shajahan-Haq AN.
Salamone JM, et al. Among authors: holloway jn.
Cancer Res. 2018 Oct 15;78(20):5723-5728. doi: 10.1158/0008-5472.CAN-18-1600. Epub 2018 Aug 17.
Cancer Res. 2018.
PMID: 30120210
Free PMC article.
Review.
Item in Clipboard
Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells.
Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D.
Oh AS, et al. Among authors: holloway jn.
Mol Endocrinol. 2001 Aug;15(8):1344-59. doi: 10.1210/mend.15.8.0678.
Mol Endocrinol. 2001.
PMID: 11463858
Item in Clipboard
A cytoplasmic substrate of mitogen-activated protein kinase is responsible for estrogen receptor-alpha down-regulation in breast cancer cells: the role of nuclear factor-kappaB.
Holloway JN, Murthy S, El-Ashry D.
Holloway JN, et al.
Mol Endocrinol. 2004 Jun;18(6):1396-410. doi: 10.1210/me.2004-0048. Epub 2004 Mar 31.
Mol Endocrinol. 2004.
PMID: 15056731
Item in Clipboard
Cite
Cite